Rosemary Waring
(Former)
51 - 60 out of 81Page size: 10
Publications
- Published
A review of xenobiotic metabolising enzymes in Parkinson's disease and motor neurone disease
Rosemary Waring & Adrian Williams, 1 Jan 2001, In: Drug Metabolism and Drug Interactions. 18, p. 79-98 20 p.Research output: Contribution to journal › Article
- Published
Detection of endocrine disruptors - from simple assays to whole genome scanning.
Rosemary Waring & David Ramsden, 19 Mar 2012, In: International Journal of Andrology.Research output: Contribution to journal › Article
- Published
The effect of plasticisers on 'sulphate supply' enzymes
Rosemary Waring & David Ramsden, 1 Dec 2005, In: Molecular and Cellular Endocrinology. 244, 1-2, p. 15-19 5 p.Research output: Contribution to journal › Article
- Published
Wide-Ranging Genomic Effects of Plasticisers and Related Compounds
Nil Turan Jurdzinski, Rosemary Waring & David Ramsden, 1 May 2008, In: Current Drug Metabolism. 9, 4, p. 285-303 19 p.Research output: Contribution to journal › Article
- Published
Endocrine disrupters: a human risk?
Rosemary Waring, 1 Dec 2005, In: Molecular and Cellular Endocrinology. 244, 1-2, p. 2-9 8 p.Research output: Contribution to journal › Review article
- Published
- Published
In utero exposure to carcinogens: epigenetics, developmental disruption and consequences in later life
Rosemary Waring, Apr 2016, In: Maturitas. 86, p. 59-63Research output: Contribution to journal › Article › peer-review
- Published
Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man
Rosemary Waring, 1 Jan 2003, In: Drug Metabolism and Drug Interactions. 19, p. 241-255 15 p.Research output: Contribution to journal › Article
- Published
- Published